» Articles » PMID: 38658753

Spatiotemporally Resolved Colorectal Oncogenesis in Mini-colons Ex Vivo

Overview
Journal Nature
Specialty Science
Date 2024 Apr 24
PMID 38658753
Authors
Affiliations
Soon will be listed here.
Abstract

Three-dimensional organoid culture technologies have revolutionized cancer research by allowing for more realistic and scalable reproductions of both tumour and microenvironmental structures. This has enabled better modelling of low-complexity cancer cell behaviours that occur over relatively short periods of time. However, available organoid systems do not capture the intricate evolutionary process of cancer development in terms of tissue architecture, cell diversity, homeostasis and lifespan. As a consequence, oncogenesis and tumour formation studies are not possible in vitro and instead require the extensive use of animal models, which provide limited spatiotemporal resolution of cellular dynamics and come at a considerable cost in terms of resources and animal lives. Here we developed topobiologically complex mini-colons that are able to undergo tumorigenesis ex vivo by integrating microfabrication, optogenetic and tissue engineering approaches. With this system, tumorigenic transformation can be spatiotemporally controlled by directing oncogenic activation through blue-light exposure, and emergent colon tumours can be tracked in real-time at the single-cell resolution for several weeks without breaking the culture. These induced mini-colons display rich intratumoural and intertumoural diversity and recapitulate key pathophysiological hallmarks displayed by colorectal tumours in vivo. By fine-tuning cell-intrinsic and cell-extrinsic parameters, mini-colons can be used to identify tumorigenic determinants and pharmacological opportunities. As a whole, our study paves the way for cancer initiation research outside living organisms.

Citing Articles

Advances in medical devices using nanomaterials and nanotechnology: Innovation and regulatory science.

Lin C, Huang X, Xue Y, Jiang S, Chen C, Liu Y Bioact Mater. 2025; 48:353-369.

PMID: 40060145 PMC: 11889687. DOI: 10.1016/j.bioactmat.2025.02.017.


Organoid models: applications and research advances in colorectal cancer.

Wu Y, Sha Y, Guo X, Gao L, Huang J, Liu S Front Oncol. 2025; 15:1432506.

PMID: 39990692 PMC: 11842244. DOI: 10.3389/fonc.2025.1432506.


Model systems to study tumor-microbiome interactions in early-onset colorectal cancer.

Richter K, Wrage M, Krekeler C, De Oliveira T, Conradi L, Menck K EMBO Mol Med. 2025; 17(3):395-413.

PMID: 39948421 PMC: 11903813. DOI: 10.1038/s44321-025-00198-3.


Harnessing 3D models to uncover the mechanisms driving infectious and inflammatory disease in the intestine.

Micati D, Hlavca S, Chan W, Abud H BMC Biol. 2024; 22(1):300.

PMID: 39736603 PMC: 11686917. DOI: 10.1186/s12915-024-02092-9.


Spatially defined microenvironment for engineering organoids.

Zhang Y, Qi F, Chen P, Liu B, Li Y Biophys Rev (Melville). 2024; 5(4):041302.

PMID: 39679203 PMC: 11646138. DOI: 10.1063/5.0198848.


References
1.
Drost J, Clevers H . Organoids in cancer research. Nat Rev Cancer. 2018; 18(7):407-418. DOI: 10.1038/s41568-018-0007-6. View

2.
Rodrigues J, Heinrich M, Moreira Teixeira L, Prakash J . 3D In Vitro Model (R)evolution: Unveiling Tumor-Stroma Interactions. Trends Cancer. 2020; 7(3):249-264. DOI: 10.1016/j.trecan.2020.10.009. View

3.
Tuveson D, Clevers H . Cancer modeling meets human organoid technology. Science. 2019; 364(6444):952-955. DOI: 10.1126/science.aaw6985. View

4.
Katt M, Placone A, Wong A, Xu Z, Searson P . In Vitro Tumor Models: Advantages, Disadvantages, Variables, and Selecting the Right Platform. Front Bioeng Biotechnol. 2016; 4:12. PMC: 4751256. DOI: 10.3389/fbioe.2016.00012. View

5.
Lee-Six H, Olafsson S, Ellis P, Osborne R, Sanders M, Moore L . The landscape of somatic mutation in normal colorectal epithelial cells. Nature. 2019; 574(7779):532-537. DOI: 10.1038/s41586-019-1672-7. View